chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shingles/diagnosed as having the shingles; Developed double vision; eye infection; redness; This spontaneous case was reported by a nurse and describes the occurrence of HERPES ZOSTER (shingles/diagnosed as having the shingles), DIPLOPIA (Developed double vision), EYE INFECTION (eye infection) and OCULAR HYPERAEMIA (redness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, METOPROLOL, ATORVASTATIN and ACETYLSALICYLIC ACID (ASPIRINE) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced HERPES ZOSTER (shingles/diagnosed as having the shingles). In February 2021, the patient experienced DIPLOPIA (Developed double vision), EYE INFECTION (eye infection) and OCULAR HYPERAEMIA (redness). The patient was treated with VALACYCLOVIR [VALACICLOVIR] for Shingles, at an unspecified dose and frequency; TOBRAMYCIN for Eye infection, at an unspecified dose and frequency and DEXAMETHASONE for Eye infection, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (shingles/diagnosed as having the shingles), DIPLOPIA (Developed double vision), EYE INFECTION (eye infection) and OCULAR HYPERAEMIA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient experienced symptoms which started 02feb2021 about two weeks later, of a rash on her forehead and faced and was diagnosed with the hives initially but within 24 hours caller was diagnosed as having the shingles by her healthcare provider.  valacyclovir was taken for 2 weeks and the medication "didn't helped the shingles got better".  Caller developed double vision, with an eyed infection and redness and was treated with valacyclovir for 10 more days by her healthcare provider.  Caller was started on tobramycin and dexamethasone ophthalmic suspension for her eyes.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Significant follow up information included reporter details, patient demographic, suspect details, concomitant medication, treatment medication added.
flu like symptoms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), outcome "not recovered", described as "flu like symptoms".  Additional Information: Consumer stated, "I am calling about the Pfizer vaccination that I received." When probed if it is COVID vaccine or any other vaccine, consumer stated, "No, I am not." When probed if calling for COVID vaccine, consumer stated, "Yes, I am." Concern: Consumer stated, "I am having flu like symptoms and I want to take some medicines (further clarification unknown) because I do not want to get sick but I do not know if it is okay to take medicine with this shot. I want to take some emergency, I do not know if you are familiar with it or not but I want to take some emergency and also I have asthma (further clarification unknown hence not captured in tab) and I do not know whether or not I can use my inhaler (Unspecified product). Now I hope all I have not to repeat this again. Do you understand what I am concerned about?" Consumer further stated, "Would you just stop and answer whether I can take anything or not and do not do this. It shouldn't be this difficult just tell me whether or not I can take this emergency medicine and whether or not I can use my inhaler please. Do not apologize anymore and just answer it if you can. I also have somebody else on the phone. I hate to be rude to you but this is irritating."  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Allergic reaction (generalized urticaria); This is a spontaneous report received from contactable reporter(s) (Physician). Other Case identifier(s):   A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: URTICARIA (non-serious), outcome "unknown", described as "Allergic reaction (generalized urticaria)".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.